Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells. - Wikidata - awgldk - TriplyDB

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

http://www.wikidata.org/entity/Q36356090

about

DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells Molecular cloning, expression, and chromosomal localization of the human earliest lymphocyte activation antigen AIM/CD69, a new member of the C-type animal lectin superfamily of signal-transmitting receptors Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor Missing self-recognition of Ocil/Clr-b by inhibitory NKR-P1 natural killer cell receptors Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytes MHC class I expression protects rat colon carcinoma cells from hepatic natural killer cell-mediated apoptosis and cytolysis, by blocking the perforin/granzyme pathway Comparative genomics of natural killer cell receptor gene clusters.Genetically linked C-type lectin-related ligands for the NKRP1 family of natural killer cell receptors An autosomal dominant locus, Nka, mapping to the Ly-49 region of a rat natural killer (NK) gene complex, controls NK cell lysis of allogeneic lymphocytes The lectin-like receptor KLRE1 inhibits natural killer cell cytotoxicity Requirement of homotypic NK-cell interactions through 2B4(CD244)/CD48 in the generation of NK effector functions Functional role for Syk tyrosine kinase in natural killer cell-mediated natural cytotoxicity Complexity and Diversity of the NKR-P1:Clr (Klrb1:Clec2) Recognition Systems Functional CD32 molecules on human NK cells.Unimpaired autoreactive T-cell traffic within the central nervous system during tumor necrosis factor receptor-mediated inhibition of experimental autoimmune encephalomyelitis.Listeria monocytogenes infection affects a subset of Ly49-expressing NK cells in the rat Turning on natural killer cells.Ig-binding receptors on human NK cells as effector and regulatory surface molecules.The search for the missing 'missing-self' receptor on natural killer cells.In vivo suppression of NK cell cytotoxicity by stress and surgery: glucocorticoids have a minor role compared to catecholamines and prostaglandins.Induction of lectin-like transcript 1 (LLT1) protein cell surface expression by pathogens and interferon-γ contributes to modulate immune responses Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.Stress and skin leukocyte trafficking as a dual-stage process Functional Heterogeneity and Antimycobacterial Effects of Mouse Mucosal-Associated Invariant T Cells Specific for Riboflavin Metabolites.Increased susceptibility to metastasis during pro-oestrus/oestrus in rats: possible role of oestradiol and natural killer cells The lytic granules of natural killer cells are dual-function organelles combining secretory and pre-lysosomal compartments.Exogenously-induced, natural killer cell-mediated neuronal killing: a novel pathogenetic mechanism.In vivo treatment with monoclonal antibody 3.2.3 selectively eliminates natural killer cells in rats.A novel surface antigen expressed by a subset of human CD3- CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function.The generation of natural killer (NK) cells from NK precursor cells in rat long-term bone marrow cultures Control of rat natural killer cell-mediated allorecognition by a major histocompatibility complex region encoding nonclassical class I antigens.Altered major histocompatibility complex restriction in the NK1.1+Ly-6Chi autoreactive CD4+ T cell subset from class II-deficient mice.NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity Ly-49-independent natural killer (NK) cell specificity revealed by NK cell clones derived from p53-deficient mice.Cloning and characterization of 5E6(Ly-49C), a receptor molecule expressed on a subset of murine natural killer cells A major histocompatibility complex class II restriction for BioBreeding/Worcester diabetes-inducing T cells.Nonstochastic coexpression of activation receptors on murine natural killer cells Mouse Ly-49A interrupts early signaling events in natural killer cell cytotoxicity and functionally associates with the SHP-1 tyrosine phosphatase.Rat spleen dendritic cells express natural killer cell receptor protein 1 (NKR-P1) and have cytotoxic activity to select targets via a Ca2+-dependent mechanism Permanent CD8(+) T cell depletion prevents proteinuria in active Heymann nephritis.

P2860

Q24295237-1B5A6D79-8047-4BFB-8520-1F328089B75C Q24310589-98153825-1D79-4085-997D-0B2B8DF4688D Q24318464-B3DFC9F9-C07B-4E79-886A-0B5AB84EA8FD Q24633504-1ACAD2D6-62AE-4648-B082-9B6623DDC7D7 Q24675597-9B3B422C-DF04-451B-97B5-A746B8B7EE87 Q24800395-C5DAB180-F252-4E9F-B8D2-113F2E03D28E Q24816578-652156AC-ABBF-4FC8-8B4D-ACF19CD8896D Q28186896-3F5CE755-E3ED-42BA-824E-4842F5B7FC92 Q28564165-F426D033-86C6-4739-BA20-D1911E13996F Q28566558-74113476-CEC3-44FC-A23F-54B032A540B8 Q28593445-A031D5ED-0270-48DD-8849-AAF593B1FBE9 Q28610853-C7ECA69D-1879-40D6-A3A9-600939587CE6 Q33696425-0FFBE4E9-C0EA-4F7F-A0FD-51A3F0E4CBCD Q33747251-B983720C-C1C4-4DE3-9E3B-507CC35F616B Q33753656-B0F34728-A1F1-4E88-BD1F-789FF12FC59F Q33778675-072F2399-014B-4A13-A49F-E1551F0FC892 Q33894477-86C7FD2B-1D8D-4A5A-A3E9-8E31179605C7 Q34552149-B692016F-BED9-4C72-8D81-C01E55C90EC3 Q34592455-B234830A-5D31-4420-A8D3-1C3744F0E63A Q35067176-806289BE-C75B-482E-8736-821810288A5C Q35515622-41DFF842-A948-4D07-A19E-F48DAC8F9DDE Q35553521-C4E25383-748B-4E55-AC18-5AD03393333F Q35661107-098B28DC-191A-43C8-A9D3-2E9CEA7D0E64 Q35815577-B70EF4C7-7B01-43CD-9807-519B6B8193E4 Q36136368-2C3F5568-2AF0-41B9-B7F7-C44A200459A1 Q36224120-E17494FF-135C-49DB-A726-FC865181A23D Q36231798-347F4D86-85ED-49DA-A7D6-86A89C5E3719 Q36350283-A61FE2F4-54FE-4806-BCBB-DA4CC98A90F7 Q36350702-9AD79E0D-B58D-47AB-89E9-179D83991FC2 Q36351948-DC06914C-D5DF-430F-BEF3-E2DBDDD85DE8 Q36363553-353F0A4F-B13A-443C-A0D7-4505D9D1FE95 Q36364089-4AF747B6-5DC9-4F24-AE91-C13011CC5356 Q36364778-EF8888AD-8C3E-434F-A209-E84A633C05F7 Q36364791-F2DDFB73-D33F-47EE-820D-2DB725BB6F99 Q36365276-E27E7710-C17D-4028-A0DD-0A5ED6F64EA3 Q36365755-F8B987D7-A9CA-4B17-A41B-77662DED4419 Q36368400-1991CD45-D47A-4454-A765-77603ED9E706 Q36376816-38D36CC4-E196-4C5A-88E2-058A2CC54AF5 Q36380421-D93B739B-205F-432C-BCF7-41CF74B1F152 Q36401277-8915C28A-1003-4E66-933D-4C1FF7BCA80E

P2860

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells.

http://www.wikidata.org/entity/Q36356090

description

1989 nî lūn-bûn

@nan

1989年の論文

@ja

1989年学术文章

@wuu

1989年学术文章

@zh-cn

1989年学术文章

@zh-hans

1989年学术文章

@zh-my

1989年学术文章

@zh-sg

1989年學術文章

@yue

1989年學術文章

@zh

1989年學術文章

@zh-hant

name

Monoclonal antibody to a trigg ...... hokine-activated killer cells.

@ast

Monoclonal antibody to a trigg ...... hokine-activated killer cells.

@en

type

label

Monoclonal antibody to a trigg ...... hokine-activated killer cells.

@ast

Monoclonal antibody to a trigg ...... hokine-activated killer cells.

@en

prefLabel

Monoclonal antibody to a trigg ...... hokine-activated killer cells.

@ast

Monoclonal antibody to a trigg ...... hokine-activated killer cells.

@en

P1433

Q36356090-411C3FE6-FB2D-43C0-9F1B-4084DF44B01A

P1476

Q36356090-6393293E-4752-49DF-83A3-B9AF8ABFC48E

P2093

Q36356090-0CD17F1B-4304-4CCB-AD51-D88EB49290C1

Q36356090-3569FC5F-1254-4AD0-B408-D652EEDFDAF4

Q36356090-678A11FE-B326-41A8-920D-DBC6879BC560

Q36356090-82F77107-E9B2-425F-B246-3C1DED8D2B3D

Q36356090-8B301407-0DB9-4EFA-B192-3F5DE2868530

Q36356090-E4B43D9B-CF6B-4562-9A9A-9CF28FD50F6A

P2860

Q36356090-0787CCEC-A248-4B09-A6D1-FB527E4406C0

Q36356090-1DD5A3CE-6ECC-4DDD-81A9-B1D77248A180

Q36356090-20EDBB20-756F-4272-AAAF-298D6B9A7A3B

Q36356090-2E19213B-23A2-466E-9BB0-9CFF1D5B2E26

Q36356090-329616B8-C32C-4D99-8B01-D140E87E550F

Q36356090-3956259F-57C1-4A40-B231-FD6E94FE566C

Q36356090-3F2EFDF3-1053-4488-8708-DCC4B3FBB0D9

Q36356090-4BD96934-F905-4F09-A314-D7D6D9E93ED2

Q36356090-56CAD22E-0599-4CBD-BC4A-D7F3DBCA0A45

Q36356090-6F63BF2D-3836-4591-9663-975236B20EE6

P304

Q36356090-129BDCFD-FAFF-4518-82A5-B25ABC9318A4

P31

Q36356090-96F5E45D-ACA1-4D55-99DA-B5B5664A8CD8

P356

Q36356090-C5F43DB3-E5FA-4557-8719-95FBAC048E11

P407

Q36356090-3FDEC21E-AD2C-4618-B620-A94E870CD628

P433

Q36356090-4D2C8C8C-E588-4E91-A3CC-38AC21AD478C

P478

Q36356090-29294AC7-7011-4FCC-A4CA-CAD4D5D765C6

P577

Q36356090-9E9588C5-DDF2-4AC5-8AA5-2457F63411D6

P5875

Q36356090-B5FBB00B-6F83-46FC-B20D-9400DDE69804

P698

Q36356090-BEB84657-1E56-40CD-B995-23FB19A1E989

P921

Q36356090-CD0BA9EE-3977-4810-8F6B-0322001A17B9

P932

Q36356090-52C15CAD-622B-4C01-ABEA-FF7866F1ED09

P356

P1433

Journal of Experimental Medicine

P1476

Monoclonal antibody to a trigg ...... hokine-activated killer cells.

@en

P2093

A B DeLeo

http://www.w3.org/2001/XMLSchema#string

J C Hiserodt

http://www.w3.org/2001/XMLSchema#string

M W Olszowy

http://www.w3.org/2001/XMLSchema#string

N L Vujanovic

http://www.w3.org/2001/XMLSchema#string

R B Herberman

http://www.w3.org/2001/XMLSchema#string

W H Chambers

http://www.w3.org/2001/XMLSchema#string

P2860

Adoptive immunotherapy of cancer: accomplishments and prospects.

Generation of monoclonal antibodies to a human natural killer clone. Characterization of two natural killer-associated antigens, NKH1A and NKH2, expressed on subsets of large granular lymphocytes.

Enhancement of natural killer function through activation of the T11 E rosette receptor

Laminin inhibits the recognition of tumor target cells by murine natural killer (NK) and natural cytotoxic (NC) lymphocytes.

Human neutrophil Fc gamma receptor distribution and structure

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

Lymphokine-activated killer cells. Analysis of progenitors and effectors.

Interleukin 2 promotes growth and cytolytic activity in human T3+4-8- thymocytes.

Adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2.

The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.

P304

1373-1389

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.169.4.1373

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

169

http://www.w3.org/2001/XMLSchema#string

P577

1989-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

275014658

http://www.w3.org/2001/XMLSchema#string

P698

2466943

http://www.w3.org/2001/XMLSchema#string

P921

P932

2189246

http://www.w3.org/2001/XMLSchema#string